Certified by Founder Lodge
TCV
United States - Menlo Park, California
INVESTOR
1 Disclosed Funding Rounds $38,000,000
15 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 1995, TCV is a leading provider of capital to multi-stage companies in the technology industry. TCV has invested over $17 billion in more than 350 technology companies over the las
| Company | Date | Round | Raised |
|---|---|---|---|
 Arize AI |
September, 08 ,2022 | Series B | $38,000,000 |
 Celonis |
August, 23 ,2022 | Series D | $400,000,000 |
 Aidoc |
June, 16 ,2022 | Series D | $110,000,000 |
 Devo |
June, 02 ,2022 | Series F | $100,000,000 |
 Evisort |
May, 11 ,2022 | Series C | $100,000,000 |
 Syllable |
April, 25 ,2022 | Series C | $40,000,000 |
 Reforge |
March, 03 ,2022 | Series B | $60,000,000 |
 Darwinbox |
January, 25 ,2022 | Series D | $72,000,000 |
 Passport |
January, 25 ,2022 | Series B | $39,000,000 |
 BenchSci |
January, 24 ,2022 | Series C | $63,000,000 |
 Instawork |
May, 19 ,2023 | Series D | $60,000,000 |
 Legit Security |
September, 21 ,2023 | Series B | $40,000,000 |
 Nourish |
March, 28 ,2024 | Series A | $35,000,000 |
 Nagomi Security |
April, 25 ,2024 | Unknown | $30,000,000 |
 Zepz |
October, 08 ,2024 | Unknown | $267,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
